HighMark Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

HighMark Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104K	Hold	547	–	–	0.03%	122
2026 Q1	$92.4K	Hold	547	–	–	0.04%	117
2025 Q4	$92.4K	Hold	547	–	–	0.04%	115
2025 Q3	$79K	Hold	547	–	–	0.03%	129
2025 Q2	$69.3K	Hold	547	–	–	0.03%	134
2025 Q1	$70K	Hold	547	–	–	0.04%	109
2024 Q4	$72.4K	Hold	547	–	–	0.04%	102
2024 Q3	$79.7K	Hold	547	–	–	0.04%	119
2024 Q2	$75.1K	Hold	547	–	–	0.05%	117
2024 Q1	$75.1K	Hold	547	–	–	0.05%	113
2023 Q4	$74.4K	Hold	547	–	–	0.05%	110
2023 Q3	$66.9K	Hold	547	–	–	0.06%	102
2023 Q2	$69.5K	Hold	547	–	–	0.05%	99
2023 Q1	$70.7K	Hold	547	–	–	0.06%	113
2022 Q4	$71.9K	Hold	547	–	–	0.05%	90
2022 Q3	$64K	Hold	547	–	–	0.05%	84
2022 Q2	$64K	Hold	547	–	–	0.05%	89
2022 Q1	$71K	Hold	547	–	–	0.05%	89
2021 Q4	$84K	Hold	547	–	–	0.05%	88
2021 Q3	$89K	Hold	547	–	–	0.07%	83
2021 Q2	$90K	Sell	547 -56	-9%	-$8.63K	0.07%	81
2021 Q1	$91K	Hold	603	–	–	0.07%	72
2020 Q4	$91K	Hold	603	–	–	0.08%	70
2020 Q3	$82K	Hold	603	–	–	0.07%	74
2020 Q2	$82K	Hold	603	–	–	0.09%	60
2020 Q1	$65K	Hold	603	–	–	0.08%	58
2019 Q4	$72K	Buy	+603	New	+$67.3K	0.08%	65

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

HighMark Wealth Management's IBB Position: Q2 2026 in Review

HighMark Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 547 shares worth $104K. The position accounts for 0.03% of the portfolio, ranked #122.

HighMark Wealth Management first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

HighMark Wealth Management held 547 shares of iShares Biotechnology ETF worth $104K as of Q2 2026.
HighMark Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.03% of HighMark Wealth Management's portfolio in Q2 2026, its #122 holding.
HighMark Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.